Literature DB >> 26156076

Migraine aura symptoms: Duration, succession and temporal relationship to headache.

Michele Viana1, Mattias Linde2, Grazia Sances3, Natascia Ghiotto3, Elena Guaschino3, Marta Allena3, Salvatore Terrazzino4, Giuseppe Nappi3, Peter J Goadsby5, Cristina Tassorelli6.   

Abstract

BACKGROUND: As there are no biological markers, a detailed description of symptoms, particularly temporal characteristics, is crucial when diagnosing migraine aura. Hitherto these temporal aspects have not been studied in detail.
METHODS: We conducted a prospective diary-aided study of the duration and the succession of aura symptoms and their temporal relationship with headache.
RESULTS: Fifty-four patients completed the study recording in a diary the characteristics of three consecutive auras ( ITALIC! n = 162 auras). The median duration of visual, sensory and dysphasic symptoms were 30, 20 and 20 minutes, respectively. Visual symptoms lasted for more than one hour in 14% of auras ( ITALIC! n = 158), sensory symptoms in 21% of auras ( ITALIC! n = 52), and dysphasic symptoms in 17% of auras ( ITALIC! n = 18). Twenty-six percent of patients had at least one aura out of three with one symptom lasting for more than one hour. In aura with multiple symptoms the subsequent symptom, second versus first one or third versus second, might either start simultaneously (34 and 18%), during (37 and 55%), with the end (5 and 9%), or after (24 and 18%) the previous aura symptom. The headache phase started before the aura (9%), simultaneously with the onset of aura (14%), during the aura (26%), simultaneously with the end of aura (15%) or after the end of aura (36%).
CONCLUSION: We provide data to suggest that symptoms may last longer than one hour in a relevant proportion of auras or migraine with aura patients, and that there is a high variability of scenarios in terms of time relationship among aura symptoms and between aura and headache. © International Headache Society 2015.

Entities:  

Keywords:  Migraine with aura; duration; headache; symptoms; temporal features; time

Mesh:

Year:  2015        PMID: 26156076     DOI: 10.1177/0333102415593089

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  13 in total

Review 1.  Migraine with prolonged aura: phenotype and treatment.

Authors:  Michele Viana; Shazia Afridi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-11-16       Impact factor: 3.000

Review 2.  Pathophysiology of Migraine: A Disorder of Sensory Processing.

Authors:  Peter J Goadsby; Philip R Holland; Margarida Martins-Oliveira; Jan Hoffmann; Christoph Schankin; Simon Akerman
Journal:  Physiol Rev       Date:  2017-04       Impact factor: 37.312

3.  Non-invasively triggered spreading depolarizations induce a rapid pro-inflammatory response in cerebral cortex.

Authors:  Tsubasa Takizawa; Tao Qin; Andreia Lopes de Morais; Kazutaka Sugimoto; Joon Yong Chung; Liza Morsett; Inge Mulder; Paul Fischer; Tomoaki Suzuki; Maryam Anzabi; Maximilian Böhm; Wen-Sheng Qu; Takeshi Yanagisawa; Suzanne Hickman; Joseph El Khoury; Michael J Whalen; Andrea M Harriott; David Y Chung; Cenk Ayata
Journal:  J Cereb Blood Flow Metab       Date:  2019-06-26       Impact factor: 6.200

4.  Migraine-Like Visual Auras Among Traumatized Cambodians with PTSD: Fear of Ghost Attack and Other Disasters.

Authors:  Devon E Hinton; Ria Reis; Joop de Jong
Journal:  Cult Med Psychiatry       Date:  2018-06

Review 5.  Non-headache symptoms in migraine patients.

Authors:  Ping-Kun Chen; Shuu-Jiun Wang
Journal:  F1000Res       Date:  2018-02-14

6.  Prolonged migraine aura: new insights from a prospective diary-aided study.

Authors:  Michele Viana; Grazia Sances; Mattias Linde; Giuseppe Nappi; Farihah Khaliq; Peter J Goadsby; Cristina Tassorelli
Journal:  J Headache Pain       Date:  2018-08-31       Impact factor: 7.277

Review 7.  Symptoms related to the visual system in migraine.

Authors:  Robin M van Dongen; Joost Haan
Journal:  F1000Res       Date:  2019-07-30

Review 8.  Spreading depression as a preclinical model of migraine.

Authors:  Andrea M Harriott; Tsubasa Takizawa; David Y Chung; Shih-Pin Chen
Journal:  J Headache Pain       Date:  2019-05-02       Impact factor: 7.277

Review 9.  Current Evidence on Potential Uses of MicroRNA Biomarkers for Migraine: From Diagnosis to Treatment.

Authors:  Parisa Gazerani
Journal:  Mol Diagn Ther       Date:  2019-12       Impact factor: 4.074

10.  Aura in Cluster Headache: A Cross-Sectional Study.

Authors:  Ilse F de Coo; Leopoldine A Wilbrink; Gaby D Ie; Joost Haan; Michel D Ferrari
Journal:  Headache       Date:  2018-06-22       Impact factor: 5.887

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.